Can Psoriasis Leave Scars or Just Marks?

Psoriasis is a chronic autoimmune condition where the body triggers inflammation, causing skin cells to multiply rapidly. This leads to the formation of thick, scaly, and inflamed patches called plaques. When these plaques resolve, a common concern is whether the active disease leaves behind permanent damage. The answer requires a clear distinction between a true structural scar and a temporary residual pigmentation mark.

Psoriasis and the Potential for True Scarring

Typical psoriasis plaques rarely result in true scarring because the inflammation generally remains confined to the epidermis, the outermost layer of the skin. A true scar is defined by permanent textural changes, such as raised or depressed areas, that occur when damage extends deep into the dermis. This deep injury triggers the replacement of normal skin tissue with fibrous collagen, leading to permanent marks like atrophic or hypertrophic scars.

The disease itself does not typically initiate this level of dermal damage. True scarring is not a common outcome of an uncomplicated psoriasis flare, and usually results from a secondary event rather than the primary disease process.

Distinguishing Residual Pigmentation Marks

What often gets mistaken for a scar is a change in skin color, known as post-inflammatory pigmentation. These marks are purely color-based and do not involve the permanent change in skin texture that defines a scar. This pigmentation is a direct result of the body’s intense inflammatory response during a flare, which temporarily affects the production and distribution of melanin.

The marks can manifest as two distinct types: Post-Inflammatory Hyperpigmentation (PIH), appearing as dark spots, or Post-Inflammatory Hypopigmentation, presenting as lighter patches. PIH occurs when inflammation stimulates melanocytes to overproduce melanin. Conversely, severe or prolonged inflammation can sometimes damage the melanin-producing cells, leading to a loss of pigment.

These pigmentation marks are temporary, often fading over a period ranging from several months to a few years as the skin naturally regenerates. Unlike true scars, these color changes are confined to the upper layers and will eventually resolve.

Factors That Elevate Scarring Risk

While psoriasis plaques are usually superficial, certain factors can push the damage deeper, increasing the risk of true scarring. The most common trigger is external trauma, such as persistent scratching, rubbing, or picking at the itchy plaques. This mechanical damage breaks the skin barrier, extending the injury into the dermis and initiating the fibrous tissue replacement that results in a scar.

Another compounding factor is the development of a secondary infection within a lesion, which deepens the inflammatory process and leads to more extensive tissue destruction. Furthermore, the Koebner phenomenon means that any skin injury can trigger the formation of a new psoriasis lesion in that exact spot. This response can exacerbate the damage from trauma, increasing the likelihood of a permanent textural scar.

Strategies for Minimizing and Treating Marks

The most effective strategy for preventing both true scars and prolonged pigmentation marks is to maintain strict control over the underlying inflammation. Consistent adherence to a prescribed treatment plan minimizes the intensity and duration of flares, which are the root cause of the discoloration. Avoiding all forms of trauma to the skin, especially scratching and picking, is necessary to prevent the deep dermal damage that can cause true scars.

To manage existing pigmentation, daily sun protection is a powerful intervention, as UV exposure can significantly darken and prolong PIH. Dermatologists may recommend topical treatments to accelerate fading, such as retinoids, azelaic acid, or hydroquinone, which work by regulating pigment production. Procedures like chemical peels or certain laser treatments may be used, although caution is needed, as any injury to the skin carries the risk of triggering a new psoriasis flare.